San Antonio, Texas-based BME’s nitinol implants are designed to treat deformities of the foot, ankle, hand and wrist.
“BME’s technology is an excellent complement to our comprehensive portfolio of solutions that spans all of orthopaedics,” DePuy Synthes chairman Ciro Römer said in prepared remarks. “The BME portfolio will be integrated into our trauma platform, where we will be able to expand the availability of these solutions, increase the pace of innovation in this area, and reach more patients around the world. We look forward to welcoming the BME employees to DePuy Synthes.”
In March, BioMedical Enterprises announced the U.S. launch of its Elite small bone fixation device. The company won 510(k) clearances in January 2014 for the Hammertoe 2 intramedullary bone fastener and another in November of that year for the Speed line of shape-memory fixation devices.